As of 2024-12-12, the Relative Valuation of Mesa Laboratories Inc (MLAB) is (1,518.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 128.78 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -1279.5%.
The range of the Relative Valuation is (1,625.01) - (1,472.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.9x - 41.4x | 38.4x |
| Forward P/E multiples | 27.2x - 32.5x | 28.7x |
| Fair Price | (1,625.01) - (1,472.10) | (1,518.92) |
| Upside | -1361.8% - -1243.1% | -1279.5% |
| Date | P/E |
| 2024-12-11 | -2.86 |
| 2024-12-10 | -2.85 |
| 2024-12-09 | -2.90 |
| 2024-12-06 | -2.74 |
| 2024-12-05 | -2.72 |
| 2024-12-04 | -2.79 |
| 2024-12-03 | -2.72 |
| 2024-12-02 | -2.69 |
| 2024-11-29 | -2.59 |
| 2024-11-27 | -2.62 |
| 2024-11-26 | -2.57 |
| 2024-11-25 | -2.51 |
| 2024-11-22 | -2.41 |
| 2024-11-21 | -2.23 |
| 2024-11-20 | -2.18 |
| 2024-11-19 | -2.20 |
| 2024-11-18 | -2.28 |
| 2024-11-15 | -2.26 |
| 2024-11-14 | -2.31 |
| 2024-11-13 | -2.38 |
| 2024-11-12 | -2.48 |
| 2024-11-11 | -2.63 |
| 2024-11-08 | -2.63 |
| 2024-11-07 | -2.61 |
| 2024-11-06 | -2.97 |
| 2024-11-05 | -2.67 |
| 2024-11-04 | -2.62 |
| 2024-11-01 | -2.61 |
| 2024-10-31 | -2.52 |
| 2024-10-30 | -2.54 |
| 2024-10-29 | -2.49 |
| 2024-10-28 | -2.50 |
| 2024-10-25 | -2.50 |
| 2024-10-24 | -2.57 |
| 2024-10-23 | -2.65 |
| 2024-10-22 | -2.96 |
| 2024-10-21 | -2.95 |
| 2024-10-18 | -3.00 |
| 2024-10-17 | -2.94 |
| 2024-10-16 | -2.96 |
| 2024-10-15 | -2.89 |
| 2024-10-14 | -2.84 |
| 2024-10-11 | -2.79 |
| 2024-10-10 | -2.71 |
| 2024-10-09 | -2.75 |
| 2024-10-08 | -2.77 |
| 2024-10-07 | -2.81 |
| 2024-10-04 | -2.95 |
| 2024-10-03 | -2.89 |
| 2024-10-02 | -2.92 |